MBRX Wutah bathi saben saham ing taun lumaku Moleculin

Simbol resmi perusahaan moleculin.com (MBRX)

Year-over-year EPS growth rates indicate scaling potential for Moleculin Biotech, Inc. (MBRX) through the licensing of unique drug formulas. The 89.20 metric confirms the current level, which is supported by patent protection for liposomal delivery and strict FDA oversight. Price stability is ensured by the minimal impact of global conflicts and a reliable US jurisdiction that precludes trade sanctions.

Wutah bathi resik saben saham ing taun iki moleculin.com (MBRX): kanggo periode 04.07.2022 - 15.11.2026

Rincian analitis lan laporan data perusahaan moleculin.com (MBRX)

- rega saiki lan proyeksi nilai saham:
Bagan kutipan Moleculin|MBRX - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar Moleculin Biotech|MBRX - Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Buku saben Saham Moleculin Biotech|MBRX - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku moleculin.com|MBRX - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Utang Agregat marang Ekuitas Moleculin Biotech, Inc.|MBRX - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Moleculin|MBRX - Utang perusahaan|Rasio utang marang aset resik Moleculin Biotech, Inc.|MBRX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Moleculin Biotech|Koefisien jangkoan perantara moleculin.com
- rincian bathi lan kelipatan pasar:
MBRX - Bathi resik perusahaan|Bathi mangsa ngarep Moleculin Biotech, Inc.|MBRX - Rasio rega marang bathi|Rasio prakiraan rega marang bathi Moleculin|MBRX - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Moleculin Biotech|MBRX - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Moleculin Biotech|MBRX - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan moleculin.com|MBRX - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Moleculin Biotech, Inc.
- statistik dodolan lan pendapatan perusahaan:
MBRX - Pendapatan perusahaan|Prakiraan pendapatan perusahaan Moleculin Biotech Inc|MBRX - Multiplikator P/S|Rasio kapitalisasi marang dodolan sing dikarepake Moleculin Biotech, Inc.
Analisis dhasar perusahaan:moleculin.com (MBRX)
Sampel barang Moleculin Biotech, Inc.

Identifying fundamentally resilient assets requires an analysis of real income dynamics. This indicator measures the relative change in earnings per share (EPS) over twelve months, reflecting the efficiency of capital generation. For Moleculin Biotech, Inc. (MBRX), this calculation demonstrates the financial return from the development of rare oncology therapies. It is critical for investors to correlate the pace of patent monetization with the annual percentage growth of net earnings per share. Analysis of this chart allows for the timely identification of the risk of overpaying for the asset.

Pesaing utama

Dinamika bathi saben saham ing taun lumaku GERN (Geron Bio)|Wutah bathi saben saham ing taun lumaku Nanobiotix S.A.|Wutah bathi saben saham ing taun lumaku BCYC|Wutah bathi ing taun lumaku CTMX|Wutah bathi ing taun lumaku Perspective Therapeutics Inc (CATX)|Genelux - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku MOLN (Molecular Partners)|Oncolytics Biotech Inc. - Wutah bathi ing taun lumaku|Dinamika bathi saben saham ing taun lumaku LSTA|galeratx.com (GRTX) - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Molecular Templates Inc (MTEM)